Email Newsletters

Life Sciences

Stryker Sells Costly Division

Michigan-based biotech company Stryker Corp. is cutting ties with its division that cost the company $1.35 million...

French Firm Closes Acquisition Of Framingham’s GTC

The $18.3-million acquisition of Framingham-based GTC Biotherapeutics Inc. by LFB Biotechnologies of France has been completed.LFB bought...

Thermo Fisher To Buy Australian Firm

Waltham-based Thermo Fisher Scientific Inc. has signed an agreement to acquire Lomb Scientific.Lomb is a provider of...

SeraCare Wraps Up Profitable Year

Milford-based SeraCare Life Sciences Inc. said it turned a $6.7-million profit on $50.4 million in revenue for...
ADVERTISEMENT

ACT Seeks FDA Approval For Stem Cell Study

Advanced Cell Technology Inc. of Marlborough has filed an application with the U.S. Food and Drug Administration...

Cambridge Firm Hires CFO From Marlborough’s Qteros

Acceleron Pharma Inc. has hired Kevin F. McLaughlin, former senior vice president and CFO of Marlborough's Qteros...

ACT Gets FDA Go Ahead

Marlborough-based Advanced Cell Technology has received government approval to move forward on clinical testing for an eye...

Genzyme To Sell Diagnostics Unit For $265M

Cambridge-based biotech and pharmaceuticals giant Genzyme Corp. has agreed to sell its diagnostic products business to Sekisui...
ADVERTISEMENT

RXi Loss Grows In Q3

Worcester's RXi Pharmaceuticals Corp. lost $4.1 million in the third quarter compared to a $2.9-million loss a...

MetroWest Biotechs Benefit From Grant Program

About a dozen biotech companies across MetroWest are benefiting from a round of grant awards through the...
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA